PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsPorphyria cutanea tarda
MeSH D017119 - porphyria cutanea tarda
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D017094:Hepatic porphyrias
$
Success rate
D017119: 
Porphyria cutanea tarda
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Accord HealthcareHydroxychloroquine Hydroxychloroquine  2020-04-07   
AllerganHydroxychloroquine Hydroxychloroquine  1995-11-30   
Amneal PharmaceuticalsHydroxychloroquine Hydroxychloroquine  2018-05-15   
Appco PharmaHydroxychloroquine Hydroxychloroquine  2018-05-01   
Aurobindo PharmaHydroxychloroquine Hydroxychloroquine  1998-05-29   
Chartwell PharmaceuticalsHydroxychloroquine Hydroxychloroquine  2018-07-06   
Concordia LaboratoriesHydroxychloroquine Plaquenil  1982-01-01   
Hikma PharmaceuticalsHydroxychloroquine Hydroxychloroquine  2007-08-15   
Invatech Pharma SolutionsHydroxychloroquine Hydroxychloroquine  1996-01-27   
Laurus LabsHydroxychloroquine Hydroxychloroquine  2019-01-15   
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
0%
0/0
Phase 2
25%
1/4
Phase 3
50%
1/2
Approved: 1Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Sandoz
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use